BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Messika J, Eloy P, Roux A, Hirschi S, Nieves A, Le Pavec J, Sénéchal A, Saint Raymond C, Carlier N, Demant X, Le Borgne A, Tissot A, Debray MP, Beaumont L, Renaud-Picard B, Reynaud-Gaubert M, Mornex JF, Falque L, Boussaud V, Jougon J, Mussot S, Mal H; French Group of Lung Transplantation. COVID-19 in Lung Transplant Recipients. Transplantation 2021;105:177-86. [PMID: 33141808 DOI: 10.1097/TP.0000000000003508] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 14.0] [Reference Citation Analysis]
Number Citing Articles
1 An W, Wang Q, Kim T, Kang J. Clinical characteristics and outcome of coronavirus disease 2019 infection in patients with solid organ transplants: A systematic review and meta-analysis. Journal of Infection and Public Health 2022. [DOI: 10.1016/j.jiph.2022.02.002] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Keller M, Sun J, Mutebi C, Shah P, Levine D, Aryal S, Iacono A, Timofte I, Mathew J, Varghese A, Giner C, Agbor-enoh S. Donor-derived cell-free DNA as a composite marker of acute lung allograft dysfunction in clinical care. The Journal of Heart and Lung Transplantation 2021. [DOI: 10.1016/j.healun.2021.12.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
3 Mohanka MR, Mahan LD, Joerns J, Lawrence A, Bollineni S, Kaza V, La Hoz RM, Kershaw CD, Terada LS, Torres F, Banga A. Clinical characteristics, management practices, and outcomes among lung transplant patients with COVID-19. J Heart Lung Transplant 2021:S1053-2498(21)02317-2. [PMID: 34172387 DOI: 10.1016/j.healun.2021.05.003] [Reference Citation Analysis]
4 Suarez-Pierre A, Choudhury R, Carroll AM, King RW, Iguidbashian J, Cotton J, Colborn KL, Kennealey PT, Cleveland JC, Pomfret E, Fullerton DA. Measuring the effect of the COVID-19 pandemic on solid organ transplantation. Am J Surg 2021:S0002-9610(21)00784-4. [PMID: 34980465 DOI: 10.1016/j.amjsurg.2021.12.036] [Reference Citation Analysis]
5 Hatzikiriakidis K, West S, Ayton D, Morris H, Martin RS, Paraskeva M. When immunosuppression and COVID‐19 intersect: An exploratory qualitative study of young lung transplant recipient perceptions of daily life during a pandemic. Pediatric Transplantation. [DOI: 10.1111/petr.14281] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Messika J, Roux A, Dauriat G, Pavec JL. Lung Transplantation in the COVID-19 Era: A Multi-Faceted Challenge. Respiratory Medicine and Research 2021. [DOI: 10.1016/j.resmer.2021.100866] [Reference Citation Analysis]
7 Colombo C, Cipolli M, Daccò V, Medino P, Alghisi F, Ambroni M, Badolato R, Battistini F, Bignamini E, Casciaro R, Ciciriello F, Collura M, Comello I, Francalanci M, Ficili F, Folino A, Leonardi S, Leonetti G, Lucanto MC, Lucca F, Maschio M, Mencarini V, Messore B, Pisi G, Pizzamiglio G, Poli P, Raia V, Riberi L, Ros M, Rotolo N, Sepe A, Taccetti G, Vitullo P, Alicandro G. Clinical course and risk factors for severe COVID-19 among Italian patients with cystic fibrosis: a study within the Italian Cystic Fibrosis Society. Infection 2021. [PMID: 34874541 DOI: 10.1007/s15010-021-01737-z] [Reference Citation Analysis]
8 Vachtenheim J Jr, Novysedlak R, Svorcova M, Lischke R, Strizova Z. How COVID-19 Affects Lung Transplantation: A Comprehensive Review. J Clin Med 2022;11:3513. [PMID: 35743583 DOI: 10.3390/jcm11123513] [Reference Citation Analysis]
9 Laothamatas K, Hum J, Benvenuto L, Shah L, Grewal HS, Pereira M, Scheffert J, Carroll M, Nolan M, Reilly G, Lemaitre P, Stanifer BP, Sonett JR, D’ovidio F, Robbins H, Arcasoy SM. One Year Into the Pandemic: Evolving COVID-19 Outcomes in Lung Transplant Recipients, a Single-center Experience. Transplantation Direct 2022;8:e1296. [DOI: 10.1097/txd.0000000000001296] [Reference Citation Analysis]
10 Degarege A, Naveed Z, Kabayundo J, Brett-major D. Heterogeneity and Risk of Bias in Studies Examining Risk Factors for Severe Illness and Death in COVID-19: A Systematic Review and Meta-Analysis. Pathogens 2022;11:563. [DOI: 10.3390/pathogens11050563] [Reference Citation Analysis]
11 Bery AI, Kulkarni HS, Kreisel D. Editorial: COVID-19 immunology and organ transplantation. Curr Opin Organ Transplant 2021;26:258-65. [PMID: 33651004 DOI: 10.1097/MOT.0000000000000862] [Reference Citation Analysis]
12 Burgel PR, Goss C. COVID-19 outcomes in people with cystic fibrosis. Curr Opin Pulm Med 2021;27:538-43. [PMID: 34620788 DOI: 10.1097/MCP.0000000000000823] [Reference Citation Analysis]
13 Munting A, Manuel O. Viral infections in lung transplantation. J Thorac Dis 2021;13:6673-94. [PMID: 34992844 DOI: 10.21037/jtd-2021-24] [Reference Citation Analysis]
14 Roosma E, van Gemert J, de Zwart A, van Leer-buter C, Hellemons M, Berg E, Luijk B, Hoek R, van Kessel D, Akkerman O, Kerstjens H, Verschuuren E, Gan C. The effect of COVID-19 on transplant function and development of CLAD in lung transplant patients: a multicenter experience. The Journal of Heart and Lung Transplantation 2022. [DOI: 10.1016/j.healun.2022.06.011] [Reference Citation Analysis]
15 Shigemura N, Cordova F, Hayanga AJ, Criner G, Toyoda Y. Lung transplantation and coronavirus disease 2019 (COVID-19): a roadmap for the enduring pandemic. J Thorac Dis 2021;13:6755-9. [PMID: 35070359 DOI: 10.21037/jtd-21-1667] [Reference Citation Analysis]
16 Sandal S, Boyarsky BJ, Massie A, Chiang TP, Segev DL, Cantarovich M. Immunosuppression practices during the COVID-19 pandemic: A multinational survey study of transplant programs. Clin Transplant 2021;:e14376. [PMID: 34050961 DOI: 10.1111/ctr.14376] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
17 Lease ED, Budev MM. Infectious Complications in Lung Transplant Recipients. Thorac Surg Clin 2022;32:211-20. [PMID: 35512939 DOI: 10.1016/j.thorsurg.2021.12.002] [Reference Citation Analysis]
18 Sathirareuangchai S, Weon JL, Tintle S, Batra K, Yan SX, Torrealba JR. Recurrent lymphangioleiomyomatosis in a lung allograft with COVID-19: autopsy case report and literature review. Surg Exp Pathol 2021;4. [DOI: 10.1186/s42047-021-00095-2] [Reference Citation Analysis]
19 Hoek RA, Verschuuren EA, de Vries RD, Vonk JM, van Baarle D, van der Heiden M, van Gemert JP, Gore EJ, Niesters HG, Erasmus M, Hellemons ME, Scherbeijn SM, Wijbenga N, Mahtab EA, Geurtsvankessel CH, Buter CVL. High Torque tenovirus (TTV) load before first vaccine dose is associated with poor serological response to COVID-19 vaccination in lung transplant recipients. The Journal of Heart and Lung Transplantation 2022. [DOI: 10.1016/j.healun.2022.03.006] [Reference Citation Analysis]
20 Gallais F, Renaud-picard B, Solis M, Laugel E, Soulier E, Caillard S, Kessler R, Fafi-kremer S. Torque teno virus DNA load as a predictive marker of antibody response to a three-dose regimen of COVID-19 mRNA-based vaccine in lung transplant recipients. The Journal of Heart and Lung Transplantation 2022. [DOI: 10.1016/j.healun.2022.07.008] [Reference Citation Analysis]
21 Havlin J, Svorcova M, Dvorackova E, Lastovicka J, Lischke R, Kalina T, Hubacek P. Immunogenicity of BNT162b2 mRNA COVID-19 vaccine and SARS-CoV-2 infection in lung transplant recipients. J Heart Lung Transplant 2021;40:754-8. [PMID: 34120839 DOI: 10.1016/j.healun.2021.05.004] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 14.0] [Reference Citation Analysis]
22 Mahan LD, Lill I, Halverson Q, Mohanka MR, Lawrence A, Joerns J, Bollineni S, Kaza V, La Hoz RM, Zhang S, Kershaw CD, Terada LS, Torres F, Banga A. Post-infection pulmonary sequelae after COVID-19 among patients with lung transplantation. Transpl Infect Dis 2021;:e13739. [PMID: 34605596 DOI: 10.1111/tid.13739] [Reference Citation Analysis]
23 Ko KKK, Yingtaweesittikul H, Tan TT, Wijaya L, Cao DY, Goh SS, Abdul Rahman NB, Chan KXL, Tay HM, Sim JHC, Chan KS, Oon LLE, Nagarajan N, Suphavilai C. Emergence of SARS-CoV-2 Spike Mutations during Prolonged Infection in Immunocompromised Hosts. Microbiol Spectr 2022;:e0079122. [PMID: 35543562 DOI: 10.1128/spectrum.00791-22] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Novysedlak R, Vachtenheim J Jr, Stříž I, Viklický O, Lischke R, Strizova Z. SARS-CoV-2 viral load assessment in lung transplantation. Physiol Res 2021;70:S253-8. [PMID: 34913356 DOI: 10.33549/physiolres.934760] [Reference Citation Analysis]
25 Kamp JC, Hinrichs JB, Fuge J, Ewen R, Gottlieb J. COVID-19 in lung transplant recipients-Risk prediction and outcomes. PLoS One 2021;16:e0257807. [PMID: 34613977 DOI: 10.1371/journal.pone.0257807] [Reference Citation Analysis]
26 Goldman JD, Robinson PC, Uldrick TS, Ljungman P. COVID-19 in immunocompromised populations: implications for prognosis and repurposing of immunotherapies. J Immunother Cancer 2021;9:e002630. [PMID: 34117116 DOI: 10.1136/jitc-2021-002630] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
27 Beyoglu MA, Sahin MF, Turkkan S, Basaran FC, Yazicioglu A, Bektas SG, Tekce YT, Yekeler E. Vaccine Breakthrough Severe COVID-19 in a Lung Recipient. Transplant Proc 2021:S0041-1345(21)00796-X. [PMID: 34887098 DOI: 10.1016/j.transproceed.2021.11.003] [Reference Citation Analysis]
28 Lawrence A, Mahan LD, Mohanka MR, Bollineni S, Kaza V, La Hoz RM, Zhang S, Kershaw CD, Terada LS, Torres F, Banga A. Predictors and outcomes of respiratory failure among lung transplant patients with COVID-19. Clin Transplant 2021;:e14540. [PMID: 34792221 DOI: 10.1111/ctr.14540] [Reference Citation Analysis]
29 Stainer A, Amati F, Suigo G, Simonetta E, Gramegna A, Voza A, Aliberti S. COVID-19 in Immunocompromised Patients: A Systematic Review. Semin Respir Crit Care Med 2021;42:839-58. [PMID: 34918325 DOI: 10.1055/s-0041-1740110] [Reference Citation Analysis]